.After antibody-drug conjugate (ADC) specialist Seagen was actually marketed to Pfizer in 2015 for a...
.On the heels of a phase 3 succeed that neglected to blow away investors, Ironwood Pharmaceuticals i...
.Don't quit Monte Rosa Therapies right now. The Boston-based biotech is enjoying after signing a tak...
.Invite to today's Chutes & Ladders, our summary of notable leadership hirings, firings and also ...
.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the pos...
.AbbVie has returned to the source of its own antipsychotic goliath Vraylar trying to find one more ...
.GenSight Biologics is weeks off of losing cash. Once more. The biotech simply possesses sufficient ...
.Monopar Therapies is actually recouping a medication from the dump of AstraZeneca's uncommon condit...
.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...
.After forming a genetics therapy alliance with Dyno Rehabs in 2020, Roche is actually back for addi...